About us
ONCOLOGY THERAPEUTIC DEVELOPMENT
Founded in 2005 by Prof. Esteban Cvitkovic, Oncology Therapeutic Development (OTD) is a Paris-based boutique CRO spin-off from a former oncology-specialist CRO. The two major axes of our small and highly experienced team overseen by Prof. Cvitkovic, are the Clinical and Consulting groups, with an infrastructure of medical oncologists, project managers, and CRAs, supported by medical writing and admin staff. The team collaborates actively with data management, statistics, and PK/PD groups, as well as regulatory experts. Our strength lies in our diverse backgrounds, extensive oncology experience and high-level training.
Experts :
Esteban CVITKOVIC
Medical Doctor, OTD Founder and Head Consultant
About Professor Esteban CVITKOVIC
Mohamed BEKRADDA
Medical Doctor, Senior Medical Director
Management Team
Fabrice BOURDEL, MSc, Clinical Operations Director
Fabrice has an MSc in cellular and molecular biology. He has nearly 20 years experience in clinical oncology research working at the oncology-specialized CRO CAC and subsequently with AAIPharma, managing more than 20 Phase I/II clinical trials. His particular expertise lies in phase I/II oncology trial, including first-in-human agents. He also has EMA pharmacovigilance certification.
Sarah MACKENZIE, PhD, Medical Writing Manager
Sarah has a PhD in developmental biology and nearly 20 years experience in early clinical oncology with big pharma and small biotech clients while working with CAC and AAIPharma prior to joining OTD. Her experience covers regulatory clinical documents (protocols, CSRs, SAE narratives, investigator brochures, clinical summaries), preclinical reports, and peer-reviewed manuscripts, posters and abstracts.
